P
Philip S. Wang
Researcher at National Institutes of Health
Publications - 152
Citations - 48738
Philip S. Wang is an academic researcher from National Institutes of Health. The author has contributed to research in topics: Mental health & National Comorbidity Survey. The author has an hindex of 76, co-authored 148 publications receiving 45028 citations. Previous affiliations of Philip S. Wang include Harvard University & Government of the United States of America.
Papers
More filters
Journal Article
Impact of drug cost sharing on service use and adverse clinical outcomes in elderly receiving antidepressants.
Philip S. Wang,Amanda R. Patrick,Colin R. Dormuth,Malcolm Maclure,Jerry Avorn,Claire Canning,Sebastian Schneeweiss +6 more
TL;DR: The cost-sharing policies studied may have contained non-essential antidepressant use without substantially increasing mental health service utilization, and well-designed prescription drug policies should be coupled with interventions to address under-treatment.
Journal Article
Considering the costs of bipolar depression.
Ronald C. Kessler,Hagop S. Akiskal,Minnie Ames,Howard G. Birnbaum,Paul E. Greenberg,Robert M. A. Hirschfeld,Philip S. Wang +6 more
Journal ArticleDOI
Measuring the cost-effectiveness of lipid-lowering drugs in the elderly: the outcomes research and economic analysis components of the PROSPER trial.
Jerry Avorn,Josh Benner,Ian Ford,David A. Ganz,Allan Gaw,Robert J. Glynn,Joseph Jackson,A. Margot Lagaay,Sebastian Schneeweiss,Tom Walley,Philip S. Wang +10 more
TL;DR: The design of the cost-effectiveness component of the first large, randomized, placebo-controlled trial of lipid-lowering therapy in subjects aged 70 years or older is described, and the projected changes in life expectancy and cardiovascular outcome rates that would be seen with lifelong use of the drug are modeled.